Section 1 Short title
This Act may be cited as the “Lung Cancer Medicare Access to Precise Testing Act”.
Lung Cancer Medicare Access to Precise Testing Act
A BILL
To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.
Sec. 2 Requiring coverage of lung cancer biomarker testing under Medicare
in subsection (s)(2)—
in subparagraph (JJ), by adding “and” at the end; and
by adding at the end the following new subparagraph:
“(KK) lung cancer biomarker testing (as defined in subsection (nnn));”
by adding at the end the following new subsection:
“(nnn) Lung cancer biomarker testing—The term lung cancer biomarker testing means a test furnished on or after January 1, 2027, to an individual diagnosed with lung cancer for the identification of 1 or more specific biomarkers (such as genes, proteins, or other molecules) based on the analysis of such individual’s tissue, blood, or bodily fluids.”
by striking “and (HH)” and inserting “(HH)”; and
by inserting “, and (II) with respect to lung cancer biomarker testing (as defined in section 1861(nnn)), the amount paid shall be 100 percent of the reasonable charges for such testing” before the semicolon at the end.